Krystal Biotech to Present at H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Krystal Biotech, Inc. (NASDAQ: KRYS) announced its participation in the H.C. Wainwright 24th Annual Global Investment Conference in New York from September 12-14, 2022. CEO Krish Krishnan will present and meet investors on September 13. A webcast of the presentation will be available at 2:30 PM ET on the same day and can be found on the company's website. Krystal Biotech focuses on redosable gene therapies for serious diseases, leveraging proprietary technology and in-house manufacturing capabilities.

PITTSBURGH, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, announced today that the Company will participate in the H.C. Wainwright 24^th Annual Global Investment Conference in New York from September 12-14.

Krish Krishnan, Chairman and Chief Executive Officer, will deliver a presentation and host investor meetings on September 13.

A webcast of the presentation will be available here beginning at 2:30pm ET on Tuesday, September 13 and will be posted on the Investor section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing medicines for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACT:
Investors and Media:                                                                
Meg Dodge                                                      
Krystal Biotech                                                    
mdodge@krystalbio.com                                             
Source: Krystal Biotech, Inc.

FAQ

When will Krystal Biotech participate in the H.C. Wainwright Conference?

Krystal Biotech will participate in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022.

Who is presenting for Krystal Biotech at the conference?

CEO Krish Krishnan will deliver a presentation and host investor meetings on September 13, 2022.

What time is the webcast for Krystal Biotech's presentation?

The webcast of Krystal Biotech's presentation will be available at 2:30 PM ET on September 13, 2022.

Where can I find the webcast of Krystal Biotech's presentation?

The webcast of the presentation can be found on the Investor section of Krystal Biotech's website.

What is the focus of Krystal Biotech's gene therapy?

Krystal Biotech focuses on redosable gene therapies for serious diseases, including rare diseases affecting the skin and lungs.